Literature DB >> 7073953

Inhibition of human tumour clonogenicity by chlorambucil and its metabolites.

G E Goodman, A McLean, D S Alberts, S Y Chang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073953      PMCID: PMC2010986          DOI: 10.1038/bjc.1982.101

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Establishment of a cell line of human endometrial adenocarcinoma in vitro.

Authors:  H Kuramoto; S Tamura; Y Notake
Journal:  Am J Obstet Gynecol       Date:  1972-12-15       Impact factor: 8.661

2.  The metabolism of chlorambucil.

Authors:  A McLean; D Newell; G Baker; T Connors
Journal:  Biochem Pharmacol       Date:  1980-07-15       Impact factor: 5.858

3.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Authors:  S E Salmon; A W Hamburger; B Soehnlen; B G Durie; D S Alberts; T E Moon
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

  3 in total
  5 in total

1.  Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.

Authors:  P Hartvig; B Simonsson; G Oberg; I Wallin; H Ehrsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.

Authors:  H Ehrsson; I Wallin; B Simonsson; P Hartvig; G Oberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.

Authors:  E Musch; M Malek; J Peter-Katalinic; H Egge; H Rink; B Lathan; E Riedel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.

Authors:  F Y Lee; P Coe; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.